Cholinesterase (ChE), divided into two enzymes acetylcholinesterase (AChE) and butyrylcholinestarase (BChE), have been identified as potential targets in the treatment of AD, myasthenia gravis and glaucoma. The gene discussed is BCHE; the disease is glaucoma.